These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 17180919

  • 1. [Study of conformational homology for the HIV-1 gpi20 V3 loop. structural analysis of the HIV-RF and HIV-Thailand viral strains].
    Andrianov AM.
    Biomed Khim; 2006; 52(5):448-57. PubMed ID: 17180919
    [Abstract] [Full Text] [Related]

  • 2. Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.
    Andrianov AM, Anishchenko IV.
    J Biomol Struct Dyn; 2009 Oct; 27(2):179-93. PubMed ID: 19583444
    [Abstract] [Full Text] [Related]

  • 3. Conformational preferences of the HIV-1 principal neutralizing determinant.
    Andrianov AM.
    J Biomol Struct Dyn; 2005 Dec; 23(3):267-82. PubMed ID: 16218754
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Solution structure of the V3 loop of a Thailand HIV isolate.
    Gupta G, Anantharamaiah GM, Scott DR, Eldridge JH, Myers G.
    J Biomol Struct Dyn; 1993 Oct; 11(2):345-66. PubMed ID: 8286061
    [Abstract] [Full Text] [Related]

  • 10. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD.
    Biochemistry; 1996 Apr 23; 35(16):5158-65. PubMed ID: 8611499
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A, Feigelson DJ, Hayek Y, Anglister J.
    Biochemistry; 1997 Jul 15; 36(28):8619-27. PubMed ID: 9214308
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
    Ghiara JB, Ferguson DC, Satterthwait AC, Dyson HJ, Wilson IA.
    J Mol Biol; 1997 Feb 14; 266(1):31-9. PubMed ID: 9054968
    [Abstract] [Full Text] [Related]

  • 17. Negatively charged glyconanoparticles modulate and stabilize the secondary structures of a gp120 V3 loop peptide: toward fully synthetic HIV vaccine candidates.
    Gianvincenzo PD, Calvo J, Perez S, Álvarez A, Bedoya LM, Alcamí J, Penadés S.
    Bioconjug Chem; 2015 Apr 15; 26(4):755-65. PubMed ID: 25734507
    [Abstract] [Full Text] [Related]

  • 18. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 19. Computational anti-AIDS drug design based on the analysis of the specific interactions between immunophilins and the HIV-1 gp120 V3 loop. Application to the FK506-binding protein.
    Andrianov AM.
    J Biomol Struct Dyn; 2008 Aug 10; 26(1):49-56. PubMed ID: 18533725
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.